Eyas Raddad
Associate VP Portfolio Strategy And New Platforms Diabetes Research @ Eli Lilly and Company
About Eyas Raddad
Eyas Raddad serves as the Associate Vice President of Portfolio Strategy and New Platforms in Diabetes Research at Eli Lilly and Company. He has extensive experience in the pharmaceutical industry, particularly in pharmacokinetics and diabetes research, and holds an MBA from the Massachusetts Institute of Technology.